{"id":240,"date":"2018-04-04T09:01:59","date_gmt":"2018-04-04T09:01:59","guid":{"rendered":"http:\/\/h3a.cbio.uct.ac.za\/?page_id=240"},"modified":"2020-04-20T14:26:45","modified_gmt":"2020-04-20T14:26:45","slug":"dr-ken-wiley","status":"publish","type":"page","link":"https:\/\/h3africa.org\/index.php\/about\/funding-agencies\/dr-ken-wiley\/","title":{"rendered":"\u00a0Dr. Ken Wiley"},"content":{"rendered":"

[vc_row][vc_column][vc_single_image image=”2082″ img_size=”200×200″ alignment=”center” css=”.vc_custom_1539693310203{margin-top: 35px !important;}”][vc_column_text]<\/p>\n

\u00a0Dr. Ken Wiley<\/h3>\n

Program Director\u00a0Division of Genomic Medicine<\/h4>\n
\n

 <\/p>\n

Dr. Ken Wiley joined the Division of Genomic Medicine (DGM) as a program director in 2014.\u00a0 He is responsible for managing a portfolio of extramural grants and contracts related to pharmacogenomics, epigenomics and clinical informatics. He works on the following projects at the DGM: the Human Heredity and Health in Africa (H3Africa) Initiative; the Electronic Medical Records and Genomics (eMERGE) Network; the Catalog of Published Genome Wide Association Studies; and the Online Mendelian Inheritance in Man (OMIM) database.<\/p>\n

Prior to joining the DGM, Dr. Wiley leveraged his expertise in pharmacology and informatics to assist the U.S. Food and Drug Administration, Booz Allen Hamilton and Harvard University.<\/p>\n

Dr. Wiley received his Ph.D. in pharmacology in 2004 from Meharry Medical College, in collaboration with the University of Iowa.[\/vc_column_text][vc_btn title=”Read More” style=”flat” shape=”square” color=”info” align=”center” button_block=”true” link=”url:https%3A%2F%2Fwww.genome.gov%2F27559100%2Fken-wiley-phd%2F||target:%20_blank|”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Other Members<\/h3>\n
\n

[\/vc_column_text][vc_basic_grid post_type=”page” max_items=”10″ gap=”15″ item=”1019″ grid_id=”vc_gid:1587392815343-dbf6af501f3790860ac9c1bb864d7185-8″ taxonomies=”29″][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

Dr. Ken Wiley joined the Division of Genomic Medicine (DGM) as a program director in 2014. He is responsible for managing a portfolio of extramural grants and contracts related to pharmacogenomics<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":57,"menu_order":46,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","footnotes":""},"categories":[8,16],"tags":[29,126],"class_list":["post-240","page","type-page","status-publish","hentry","category-about","category-funding-agencies","tag-national-institutes-of-health-staff","tag-nhgri"],"_links":{"self":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages\/240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/comments?post=240"}],"version-history":[{"count":10,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages\/240\/revisions"}],"predecessor-version":[{"id":7174,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages\/240\/revisions\/7174"}],"up":[{"embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/pages\/57"}],"wp:attachment":[{"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/media?parent=240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/categories?post=240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/h3africa.org\/index.php\/wp-json\/wp\/v2\/tags?post=240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}